Test Code CUT Copper, Liver Tissue
Reporting Name
Copper, Liver TsUseful For
Diagnosing Wilson disease and primary biliary cirrhosis using liver tissue specimens
Method Name
Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
Liver TissueSpecimen Required
Supplies: Metal Free Specimen Vial (T173)
Container/Tube:
Preferred: Mayo metal-free specimen vial
Acceptable: Paraffin block, with no more than 1 or 2 cuts previously made
Specimen Volume: 2 mg
Collection Instructions: Two mg of liver tissue is required. This is typically a piece of tissue from a 22-gauge needle biopsy at least 2 cm long. If an 18-gauge needle is used, the tissue must be at least 1 cm in length.
Specimen Stability Information:
Fresh or formalin-fixed liver tissue specimens: Frozen (-30 to -10° C) at least 20 years
Paraffin-embedded (block) liver tissue specimens: Ambient (16 to 24° C) at least 12 1/2 years
Additional Information: Paraffin blocks will be returned 7 days after analysis is complete.
Specimen Minimum Volume
Needle biopsy: See Specimen Required; 2 mm x 2 mm (punch): 0.3 mg by dry weight
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Liver Tissue | Refrigerated (preferred) | ||
Ambient | |||
Frozen |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Special Instructions
Reference Values
<50 mcg/g dry weight
Day(s) Performed
Monday, Thursday
CPT Code Information
82525
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CUT | Copper, Liver Ts | 8198-4 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
8687 | Copper, Liver Ts | 8198-4 |
Clinical Information
Homeostatic regulation of copper metabolism is very complex. The liver is the key organ to facilitate copper storage and incorporation of copper into the transport protein ceruloplasmin. Intestinal absorption and biliary excretion also play major roles in the regulation of copper homeostasis.
Abnormal copper metabolism is associated with liver disease. Elevated serum copper concentrations are seen in portal cirrhosis, biliary tract disease, and hepatitis, probably due to excess copper that would normally be excreted in the bile is retained in circulation. In primary biliary cirrhosis, ceruloplasmin is high, resulting in high serum copper. Lesser elevations of hepatic copper are found in chronic copper poisoning, obstructive jaundice, and certain cases of hepatic cirrhosis. Reduced serum copper concentration is typical of Wilson disease (hepatolenticular degeneration). Wilson disease is characterized by liver disease, neurologic abnormalities, and psychiatric disturbances. Kayser-Fleischer rings are normally present and urinary copper excretion is increased, while serum copper and ceruloplasmin are low. Labile copper fraction (LBC fraction) is also elevated in untreated Wilson disease.
Specimen Retention Time
60 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Report Available
3 to 6 daysForms
If not ordering electronically, complete, print, and send a Gastroenterology and Hepatology Test Request (T728) with the specimen.